Market Cap: $636.61M
NI
Nuvectis Pharma, Inc.
NVCT
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $636.61M
Analysts estimated NVCT earnings of $-0.27 per share this quarter (Q2). NVCT's actual earnings were $-0.30 per share.
NVCT EPS surprise of -12.28%Analysts estimated NVCT earnings of $-0.32 per share this quarter (Q1). NVCT's actual earnings were $-0.26 per share.
NVCT EPS surprise of 17.77%Analysts estimated NVCT earnings of $-0.25 per share this quarter (Q3). NVCT's actual earnings were $-0.33 per share.
NVCT EPS surprise of -30.69%Analysts estimated NVCT earnings of $-0.26 per share this quarter (Q2). NVCT's actual earnings were $-0.30 per share.
NVCT EPS surprise of -15.34%Analysts estimated NVCT earnings of $-0.26 per share this quarter (Q4). NVCT's actual earnings were $-0.36 per share.
NVCT EPS surprise of -39.48%Analysts estimated NVCT earnings of $-0.26 per share this quarter (Q3). NVCT's actual earnings were $-0.24 per share.
NVCT EPS surprise of 6.76%Analysts estimated NVCT earnings of $-0.40 per share this quarter (Q1). NVCT's actual earnings were $-0.25 per share.
NVCT EPS surprise of 38.21%Analysts estimated NVCT earnings of $-0.37 per share this quarter (Q4). NVCT's actual earnings were $-0.41 per share.
NVCT EPS surprise of 10.13%Analysts estimated NVCT earnings of $-0.35 per share this quarter (Q3). NVCT's actual earnings were $-0.37 per share.
NVCT EPS surprise of 5.96%